Literature DB >> 16278717

Oncologic positron emission tomography: a surgical perspective.

Todd O Moore1, Landis K Griffeth.   

Abstract

Year:  2003        PMID： 16278717      PMCID： PMC1200804          DOI： 10.1080/08998280.2003.11927883

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  70 in total

1.  Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.

Authors:  Bartosz Rydzewski; Farrokh Dehdashti; Brigid A Gordon; Sharlene A Teefey; Steven M Strasberg; Barry A Siegel
Journal:  AJR Am J Roentgenol       Date:  2002-02       Impact factor: 3.959

2.  Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.

Authors:  J Y Choi; K H Lee; Y M Shim; K S Lee; J J Kim; S E Kim; B T Kim
Journal:  J Nucl Med       Date:  2000-05       Impact factor: 10.057

3.  18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study.

Authors:  E E Zervos; D C Desai; L R DePalatis; D Soble; E W Martin
Journal:  J Surg Res       Date:  2001-05-01       Impact factor: 2.192

4.  Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.

Authors:  A Frilling; K Tecklenborg; R Görges; F Weber; M Clausen; E C Broelsch
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 5.  The clinical application of positron emission tomography to colorectal cancer management.

Authors:  T H Arulampalam; D C Costa; J B Bomanji; P J Ell
Journal:  Q J Nucl Med       Date:  2001-09

6.  Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer.

Authors:  T S Kim; W K Moon; D S Lee; J K Chung; M C Lee; Y K Youn; S K Oh; K J Choe; D Y Noh
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

7.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

8.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

Authors:  R L Wahl; R L Cody; G D Hutchins; E E Mudgett
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

9.  Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.

Authors:  M Diehl; J H Risse; K Brandt-Mainz; M Dietlein; K H Bohuslavizki; P Matheja; H Lange; J Bredow; C Körber; F Grünwald
Journal:  Eur J Nucl Med       Date:  2001-11

10.  Mediastinal staging of non-small-cell lung cancer with positron emission tomography.

Authors:  R Chin; R Ward; J W Keyes; R H Choplin; J C Reed; S Wallenhaupt; A S Hudspeth; E F Haponik
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.